In plain words
An MRI scanner contains parts, such as the coil and coolant system, that need replacing long before the machine itself. The question is whether to depreciate the scanner as one asset. Significant parts with different useful lives are recognised and depreciated separately. When a part is replaced, its remaining carrying amount is removed and the new part is capitalised. Routine servicing that replaces no identified part is expensed.
Why it matters
Blended depreciation on high-value imaging and surgical equipment hides the fact that certain parts (tubes, detectors, controllers) wear out on a much shorter cycle than the host machine; without componentization, replacing a part produces an artificial loss on disposal and the remaining asset is over- or under-depreciated. Given equipment purchases running into millions of SAR, this directly affects reported profit volatility and capex planning.
Diagnostic questions
Does the equipment contain parts with a materially shorter useful life than the host machine, such as an X-ray tube or detector replaced well before the scanner itself? Is a supplier cost breakdown available at acquisition to identify and cost each significant component separately? When a component is later replaced, is the carrying amount of the replaced part derecognized rather than left in the asset base? Does an existing service contract already cover part replacement, meaning no separate component should be capitalized?
Recognition
1) At acquisition, obtain the supplier's cost breakdown (or make a reasonable estimate) to identify parts whose cost is significant relative to total cost and whose useful life differs materially from the main asset. 2) Recognize each significant component as a separate depreciable unit at initial recognition. 3) Depreciate each component over its own useful life using a method reflecting its consumption pattern. 4) When a component is replaced, derecognize the carrying amount of the replaced part (recognizing any residual loss) and capitalize the new part's cost if the general recognition criteria (probable future benefit, reliable cost) are met. 5) Treat routine servicing/inspection costs that do not replace an identified component as repairs and maintenance expense, not capital expenditure. 6) Review componentization thresholds and useful lives periodically, especially after major technology upgrades.
Measurement
Allocate the total purchase cost (including installation, calibration and directly attributable import/customs costs) across identified components using supplier cost breakdowns where available, or a reasonable estimation basis (e.g. replacement cost ratios) where a breakdown is unavailable; depreciate each component on a straight-line or usage basis reflecting its actual consumption pattern (e.g. imaging tubes may wear by scan count rather than time); reassess remaining useful life whenever a component replacement or technology change indicates the original estimate is no longer appropriate.
Presentation & disclosure
Disclose depreciation methods and useful lives by major class/component of medical equipment; disclose the effect of significant component replacements during the period, including any gain/loss on derecognition of replaced parts; disclose the carrying amount of major equipment classes and component breakdowns where material; disclose the policy threshold used for componentization.
Common mistakes
- Depreciating an entire imaging system over one blended useful life set by the main frame, causing a large artificial loss on disposal when the tube or detector is replaced
- capitalizing routine maintenance/calibration that does not meet recognition criteria as if it were a new component
- failing to derecognize the carrying amount of a replaced part, effectively double-counting cost
- using supplier list-price allocations without adjusting for installation/import costs allocated proportionately across components
- not revisiting useful lives when technology changes shorten a component'
- s expected remaining life.
Simple example
A hospital buys an MRI scanner for SAR 6,000,000, of which SAR 900,000 relates to a coil and coolant subsystem with a 5-year life against 12 years for the remaining SAR 5,100,000. At acquisition: Dr Medical equipment - MRI main unit 5,100,000 / Dr Medical equipment - MRI coil/coolant component 900,000 / Cr Cash/Payable 6,000,000. Annual depreciation: Dr Depreciation expense 605,000 / Cr Accumulated depreciation - MRI main unit 425,000 (5,100,000/12) / Cr Accumulated depreciation - MRI coil component 180,000 (900,000/5). When the coil component is replaced after 5 years at a cost of SAR 950,000, with its carrying amount fully depreciated to nil: Dr Medical equipment - MRI coil/coolant component (new) 950,000 / Cr Cash/Payable 950,000 (no disposal loss since the old component was fully depreciated).
Professional judgment
Determining materiality thresholds for componentization (what cost proportion and useful-life gap justifies separate tracking) and estimating useful lives for imaging subsystems without full supplier cost breakdowns requires judgment; entities commonly set an internal policy threshold (e.g. components exceeding 10-15% of total cost) to keep the exercise practical rather than componentizing every minor part. A further grey area is whether a bundled service/maintenance contract that already covers part replacement should reduce or eliminate separate componentization of that part.
Source basis
IAS 16 · Property, Plant and Equipment
Paragraph references
Verified against the official standard texts used in the IFRS Expert skill.
Related issues
Educational and navigation content only. Not professional advice. Does not reproduce official IFRS/IAS text. Consult the authoritative standards and qualified professionals; professional judgment may still be required.